BFC Planning, Inc.’s Co-Diagnostics CODX Stock Holding History

BFC Planning, Inc.’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25	Buy	+8	New	+$25	﹤0.01%	3391

Other funds holding CODX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BFC Planning, Inc.'s CODX Position: Q2 2026 in Review

BFC Planning, Inc. opened a new position in Co-Diagnostics (CODX) in Q2 2026: 8 shares worth $25. The stake represents ﹤0.01% of the portfolio and ranks #3391 among its holdings.

25 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

BFC Planning, Inc. held 8 shares of Co-Diagnostics worth $25 as of Q2 2026.
Co-Diagnostics was a new BFC Planning, Inc. position in Q2 2026.
Co-Diagnostics made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #3391 holding.
25 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.